2015 APHA Annual Meeting & Expo

Home Events & Meetings Annual Meeting Schedule & Program

Recorded Annual Meeting Presentations (RAMP) are now available for purchase.
Only $90 for presenters, $140 for registered attendees and $200 for non-attendees.

Online Program

339672
Tensions, Trials & Transformations – Advocacy in Practice


Monday, November 2, 2015 : 10:50 a.m. - 11:00 a.m.

David Allen, UK Faculty of Public Health, London, United Kingdom
Audio (mp3) recording Recorded Presentation (mp4)
This presentation describes the pressures of accommodating different views, opinions and relationships within the organisation in relation to policy as well as the implications of relationships with government and public health bodies.  The case of e-cigarettes will be discussed as an example of health policy and advocacy.  A joint presentation by Prof. John Ashton and Mr. David Allen.

Learning Areas:

Public health or related organizational policy, standards, or other guidelines
Public health or related public policy

Learning Objectives:
Describe the issues arising in providing and supporting a strong advocacy framework. Discuss implications for policy advocacy and communication within organizations. Identify opportunities for conflict management and options used to address the challenges.

Keyword(s): Advocacy, Organizational Change

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: David Allen joined the Faculty of Public Health (FPH) in 2013 as Chief Executive. FPH is a Faculty of the three Royal Colleges of Physicians of the United Kingdom – and is the professional body acting for 3,500 Public Health consultants, leading on education, standards and advocacy. Prior to joining FPH, David has led a number of “prevention of blindness” initiatives across the UK and helped develop a Europe-wide coalition on blindness prevention.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 3129.0: Public Health Associations: a voice for global public health